A new Alzheimer’s pill, valiltramiprosate, didn’t hit its main goal in a big trial, but here’s the twist: it actually helped people with mild memory issues who have two copies of the APOE4 gene (a high-risk group). For these folks, the drug slowed brain shrinkage and improved thinking scores compared to placebo. Side effects? Mostly nausea and appetite changes. Not a miracle cure, but definitely a glimmer of hope for those at highest risk! #Health #BodyHealth #Alzheimers